Migraine Treatment Alternatives to Paracetamol and Vasograin

Several evidence-based options exist for acute migraine and prevention.

Acute Therapies

  • Triptans (5-HT1B/1D agonists): Sumatriptan, rizatriptan, eletriptan, zolmitriptan. First-line for moderate-severe attacks. Contraindicated in CVD, uncontrolled HTN.
  • NSAIDs: Ibuprofen 400–600 mg, naproxen 500–550 mg. Effective for mild-moderate; combine with triptan for synergy.
  • Gepants (CGRP antagonists): Ubrogepant, rimegepant—no vascular contraindications.
  • Ditans: Lasmiditan—5-HT1F agonist, no vasoconstriction.
  • Anti-emetics: Metoclopramide, prochlorperazine (IV/IM in ER) aid absorption and treat nausea.

Preventive Therapies (≥4 headache days/month)

  • CGRP mAbs: Erenumab, fremanezumab, galcanezumab, eptinezumab (quarterly IV).
  • Oral preventives: Beta-blockers (propranolol), topiramate, valproate, candesartan, amitriptyline.
  • OnabotulinumtoxinA (Botox): Chronic migraine (≥15 days/month); q12 weeks.
  • Neuromodulation: Non-invasive vagal nerve, supraorbital, transcranial magnetic stimulation.

Individualize with neurologist/headache specialist. Avoid opioid/butalbital overuse (medication-overuse headache).

Migraine - Related Articles